Bespoke Extracts (BSPK) Shares Outstanding (Diluted Average) (2018 - 2025)
Bespoke Extracts' (BSPK) quarterly Shares Outstanding (Diluted Average) came in at $11.2 million in Q3 2025, up 8.93% year-on-year from $10.3 million in Q3 2024, and up 0.87% quarter-over-quarter from $11.2 million in Q2 2025.
Bespoke Extracts (BSPK) Shares Outstanding (Diluted Average) (2018 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $11.2 million for Q3 2025.
- Shares Outstanding (Diluted Average) for Q3 2025 came in at $11.2 million, up 8.93% year-over-year; the trailing twelve-month figure through Sep 2025 was $11.2 million (up 8.93% YoY), and the FY2024 annual result was $10.5 million, up 3.54% from the prior year.
- Shares Outstanding (Diluted Average) came in at $11.2 million for Q3 2025 at Bespoke Extracts, up from $11.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $11.2 million in Q3 2025 to a low of $5.2 million in Q3 2021.
- The 5-year median for Shares Outstanding (Diluted Average) is $10.2 million (2023), against an average of $9.6 million.
- Across the five-year window, Shares Outstanding (Diluted Average) surged 44.55% in 2023 and rose 0.6% in 2024, its largest moves.
- Bespoke Extracts' Shares Outstanding (Diluted Average) stood at $5.2 million in 2021, then jumped by 81.57% to $9.4 million in 2022, then gained by 8.55% to $10.2 million in 2023, then rose by 3.54% to $10.5 million in 2024, then advanced by 6.86% to $11.2 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $11.2 million (Q3 2025), $11.2 million (Q2 2025), and $11.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Bespoke Extracts | - | - | 234,175.00 | 11.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11.25 Mn |
| Jun 30, 2025 | 11.15 Mn |
| Mar 31, 2025 | 11.15 Mn |
| Dec 31, 2024 | 10.53 Mn |
| Sep 30, 2024 | 10.33 Mn |
| Jun 30, 2024 | 10.17 Mn |
| Mar 31, 2024 | 10.17 Mn |
| Dec 31, 2023 | 10.17 Mn |
| Sep 30, 2023 | 10.17 Mn |
| Jun 30, 2023 | 10.11 Mn |
| Mar 31, 2023 | 10.11 Mn |
| Dec 31, 2022 | 9.37 Mn |
| Sep 30, 2022 | 8.35 Mn |
| Jun 30, 2022 | 7.81 Mn |
| Mar 31, 2022 | 6.99 Mn |
| Aug 31, 2021 | 5.16 Mn |
| Aug 31, 2019 | 60.59 Mn |
| May 31, 2019 | 66.83 Mn |
| Aug 31, 2018 | 35.41 Mn |
| May 31, 2018 | 36.48 Mn |